NORAD and gastric cancer: We found that NORAD was highly expressed in gastric cancer cell lines compared to normal gastric epithelium cell line, GES-1 (Fig. 3A), and that NORAD expression was higher in oxaliplatin-resistant cells than their parental cells (Fig. 3B).